Drugs / GCJBP Laennec Inj.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01742013 | Jan → Aug 2013 | myalgic encephalomeyelitis/chronic fatigue syndrome | Ho Cheol Shin, M.D., Ph.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCJBP Laennec Inj. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01742013 ↗ |
| Route | Subcutaneous | “GCJBP Laennec Injection,s.c., 4ml(2ml x 2)/day, 3 times per a week, 6 weeks” NCT01742013 ↗ |